Ophthotech's IPO

Ophthotech raised a round of funding on September 25, 2013. Investors include Public.

Ophthotech is a biopharmaceutical company focusing on discovering, developing and commercializing therapies for the treatment of major ophthalmic diseases. Ophthotech's lead compound Fovista (previous…

Articles about Ophthotech's IPO: